|
Atomistry » Magnesium » PDB 5ser-5sfu » 5sfj | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Magnesium » PDB 5ser-5sfu » 5sfj » |
Magnesium in PDB 5sfj: Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-DicarboxamideEnzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide:
3.1.4.17; Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide, PDB code: 5sfj
was solved by
C.Joseph,
J.U.Peters,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5sfj:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
(pdb code 5sfj). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide, PDB code: 5sfj: Jump to Magnesium binding site number: 1; 2; 3; 4; Magnesium binding site 1 out of 4 in 5sfjGo back to Magnesium Binding Sites List in 5sfj
Magnesium binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
Mono view Stereo pair view
Magnesium binding site 2 out of 4 in 5sfjGo back to Magnesium Binding Sites List in 5sfj
Magnesium binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
Mono view Stereo pair view
Magnesium binding site 3 out of 4 in 5sfjGo back to Magnesium Binding Sites List in 5sfj
Magnesium binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
Mono view Stereo pair view
Magnesium binding site 4 out of 4 in 5sfjGo back to Magnesium Binding Sites List in 5sfj
Magnesium binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-N-(2-Phenylimidazo[1,2-A]Pyrimidin-7-Yl)-4-N-(Pyridin-2- Ylmethyl)Pyrazole-3,4-Dicarboxamide
Mono view Stereo pair view
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
Page generated: Mon Sep 30 03:35:59 2024
ISSN: ESSN 1573-4951 PubMed: 36153472 DOI: 10.1007/S10822-022-00478-X |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |